Metraipolis › archive › dc_f696d0932097

Integrating neuroimaging and plasma biomarkers to predict preclinical Alzheimer's disease progression — Europe PMC PMID:42164127

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42164127
DOI
10.3389/fneur.2026.1801239
License (as archived)
solo-consultazione
Archived
2026-11-02T18:39:27.528Z
SHA-256 of the archived text
f55c4a4288b8272ad388289b9939186cac60c10278b12045c48f33055c1c19a7
Stable URL of this page
https://metraipolis.com/documento/dc_f696d0932097

How to cite

Integrating neuroimaging and plasma biomarkers to predict preclinical Alzheimer's disease progression — Europe PMC PMID:42164127 — Europe PMC (en), https://europepmc.org/article/MED/42164127 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f696d0932097 (Metraipolis archive dc_f696d0932097, sha256 f55c4a4288b8272ad388289b9939186cac60c10278b12045c48f33055c1c19a7)
BibTeX
@misc{dcf696d0932097,
  title = {Integrating neuroimaging and plasma biomarkers to predict preclinical Alzheimer's disease progression — Europe PMC PMID:42164127},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42164127},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f696d0932097; sha256 f55c4a4288b8272ad388289b9939186cac60c10278b12045c48f33055c1c19a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42164127. Agents can read the archived copy with the MCP tool read_document.